Favorable outcome in clinically stage II melanoma patients i…
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.
Article, Chapter
Full text availability for this item
Coverage:
- 1966-01-15~present; volume:1~present;issue:1~present
Coverage:
- 1996~present; volume:65~present;issue:1~present